1.11
-0.01(-0.90%)
Currency In USD
| Previous Close | 1.11 |
| Open | 1.12 |
| Day High | 1.14 |
| Day Low | 1.09 |
| 52-Week High | 2.72 |
| 52-Week Low | 1.06 |
| Volume | 4.06M |
| Average Volume | 10.47M |
| Market Cap | 333.05M |
| PE | -0.7 |
| EPS | -1.59 |
| Moving Average 50 Days | 1.29 |
| Moving Average 200 Days | 1.67 |
| Change | 0 |
If you invested $1000 in Pacific Biosciences of California, Inc. (PACB) 10 years ago, it would be worth $195.77 as of May 01, 2025 at a share price of $1.11. Whereas If you bought $1000 worth of Pacific Biosciences of California, Inc. (PACB) shares 5 years ago, it would be worth $340.49 as of May 01, 2025 at a share price of $1.11.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
PacBio Announces Plans to Improve Methylation Detection in HiFi Chemistry
GlobeNewswire Inc.
Apr 28, 2025 1:05 PM GMT
Company licenses novel deep learning-based epigenetic models from CUHK enabling the detection of 5hmC, 5mC hemimethylation, and 6mA in standard sequencing runsMENLO PARK, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- PacBio (Nasdaq: PACB), a leading p
Davos Alzheimer’s Collaborative Selects PacBio as Technology Partner for Global Project to Advance Alzheimer’s Disease Research in North Africa
GlobeNewswire Inc.
Apr 22, 2025 1:05 PM GMT
International research team aims to develop better understanding of Alzheimer’s disease and dementia in diverse populationsMENLO PARK, Calif. and GENEVA, Switzerland , April 22, 2025 (GLOBE NEWSWIRE) -- The Davos Alzheimer’s Collaborative (DAC), a
PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million
GlobeNewswire Inc.
Apr 09, 2025 1:05 PM GMT
Implements Plan to Reduce Annualized Operating Expense Run Rate by $45 Million to $50 Million Q1 2025 Earnings Conference Call Scheduled for May 8, 2025 MENLO PARK, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced pr